ISPECIMEN INC (ISPC:NASDAQ)
$1.47 -0.03 (-2%)
Analysed ISPECIMEN INC (ISPC:NASDAQ) News Sources
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research
16-03-2026
yahoo.com
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
09-05-2026
yahoo.com
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
06-08-2026
yahoo.com
iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time
09-04-2026
yahoo.com
iSpecimen Announces 1-for-40 Reverse Stock Split
24-04-2026
yahoo.com
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
12-05-2026
yahoo.com
E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
07-08-2026
yahoo.com
E.F. Hutton & Co. Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
07-08-2026
yahoo.com
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
07-08-2026
yahoo.com
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks
20-08-2026
yahoo.com
What is the current price of ISPECIMEN INC (ISPC:NASDAQ)?
The current price of ISPECIMEN INC (ISPC:NASDAQ) is $1.47.
ISPECIMEN INC (ISPC:NASDAQ) absolute price change since previous trading day?
The absolute price change of ISPECIMEN INC (ISPC:NASDAQ) since the previous trading day is $-0.03.
ISPECIMEN INC (ISPC:NASDAQ) percentage price change since previous trading day?
The percentage price change of ISPECIMEN INC (ISPC:NASDAQ) since the previous trading day is -2%.
What is the most recent average sentiment score for ISPECIMEN INC (ISPC:NASDAQ)?
The most recent average sentiment score for ISPECIMEN INC (ISPC:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for ISPECIMEN INC (ISPC:NASDAQ)?
The most recent sentiment for ISPECIMEN INC (ISPC:NASDAQ) is .
SEC-8K** Filing Available For ISPECIMEN INC (ISPC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.